ARCHIVES

Phase III Nexavar Trial Fails Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

Duke Comprehensive Cancer Center Wins Core Grant Renewal

September 17, 2010

Eleven Chemicals Rated for Tests

September 1, 1978

In Brief: Fred Hutchinson Center celebrates Massive Move Of 36 Labs, 400 Employees to New Campus

June 25, 1993

In Brief: Weiner Elected President-Elect of AACI

February 15, 2013

Massive Opposition Building To OMB Cuts; Legislative, Court Actions Predicted

February 22, 1985

NCI, Rhone-Poulenc Sign Agreement For Taxotere Trials

June 19, 1992